News

Watch Video from the World TB Day Congressional Briefing

World TB Day Congressional Briefing

Tuberculosis – We Can Beat this Global Killer

Wednesday, March 21, 2012

A briefing and update on tuberculosis (TB), a disease that is curable but still takes the lives of 4,000 people each day and is the number one killer of people living with HIV. Special areas of focus of the briefing include US global leadership on TB, how communities are addressing the crisis, the threat of drug-resistant TB, and progress towards an effective vaccine, better medications and faster diagnostics.

Moderator: John Fawcett, Legislative Director, RESULTS Educational Fund

Video Part One: http://youtu.be/fJsVfAlS2VM

Video Part Two: http://youtu.be/v0n4ruQEp1M

Video Part Three: http://youtu.be/tiUIEA-RtgA

Speakers:

Ariel Pablos-Mendez, Assistant Administrator for Global Health at the U.S. Agency for International Development (USAID)

US Partnership in Advancing the Response to TB

Powerpoint: http://youtu.be/c9QHAldjAhg

__________________________________________________________

Carol Nyirenda, Executive Director of the Community Initiative for Tuberculosis ( TB), HIV/AIDS and Malaria plus related diseases (CITAM +), Zambia

African Leadership at all Levels Confronting TB and TB-HIV

Powerpoint: http://youtu.be/B4x9FVt2hRQ

__________________________________________________________

Jennifer Woolley, Director of Advocacy, Aeras

New Tools for TB: Investing in Long-Term Solutions

Powerpoint: http://youtu.be/8ydSujoNxlA

__________________________________________________________

Dr. Lucica Ditiu, Executive Secretary, Stop TB Partnership

US leadership is crucial in winning the TB battle

Powerpoint: http://youtu.be/EbjRHCMJ228

Co-sponsored by RESULTS Educational Fund, American Thoracic Society, Stop TB Partnership, Aeras, and Treatment Action Group

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...